|
|
Volumn 3, Issue 7, 2013, Pages
|
|
Inhibiting CTLA-4 and PD-1 boosts response
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CYTOTOXIC T LYMPHOCYTE ANTIGEN 4;
IPILIMUMAB;
NIVOLUMAB;
ARTICLE;
CANCER INHIBITION;
DISEASE SEVERITY;
DRUG EFFICACY;
HUMAN;
HYPERTRANSAMINASEMIA;
IMMUNE RESPONSE;
MELANOMA;
PHASE 1 CLINICAL TRIAL (TOPIC);
SIDE EFFECT;
T LYMPHOCYTE;
|
|
EID: 84880275887
PISSN: 21598274
EISSN: 21598290
Source Type: Journal
DOI: 10.1158/2159-8290.CD-NB2013-076 Document Type: Article |
|
Times cited : (1)
|
|
References (0)
|